WARNING

Enfortumab vedotin-ejfv is a medication used in the treatment of certain types of cancer, particularly advanced urothelial cancer (bladder cancer). Like any medication, it carries some risks and potential side effects. Here are some of the risks associated with taking Enfortumab vedotin-ejfv injection:

• Infusion Reactions: Some individuals may experience infusion reactions, which can include symptoms like fever, chills, flushing, shortness of breath, or changes in blood pressure. These reactions typically occur during or shortly after receiving the infusion and can range from mild to severe.
• Peripheral Neuropathy: Enfortumab vedotin-ejfv can cause damage to the nerves, leading to symptoms such as numbness, tingling, or weakness in the hands and feet. This condition, known as peripheral neuropathy, can be temporary or long-lasting and may affect daily activities.
• Fatigue: Feeling tired or fatigued is a common side effect of Enfortumab vedotin-ejfv treatment. This fatigue can range from mild to severe and may interfere with daily functioning.
• Decreased Blood Cell Counts: Enfortumab vedotin-ejfv can cause decreases in certain types of blood cells, including white blood cells, red blood cells, and platelets. This may increase the risk of infections, anemia, and bleeding.
• Skin Reactions: Some individuals may experience skin reactions such as rash, itching, or dry skin while receiving Enfortumab vedotin-ejfv treatment.
• Gastrointestinal Symptoms: Nausea, vomiting, diarrhea, and constipation are potential gastrointestinal side effects associated with this medication.
• Liver Toxicity: Enfortumab vedotin-ejfv can affect liver function, leading to elevated liver enzymes and potentially causing liver damage.
• Increased Risk of Infections: Treatment with Enfortumab vedotin-ejfv may increase the risk of developing infections due to its effects on the immune system.

It’s important for individuals receiving Enfortumab vedotin-ejfv treatment to be closely monitored by their healthcare provider for any signs of these side effects or other adverse reactions. Prompt reporting of any unusual symptoms can help manage these risks effectively.

Why is this medication prescribed?

Enfortumab vedotin-ejfv injection is prescribed for the treatment of locally advanced or metastatic urothelial cancer in adult patients who have previously received a programmed death receptor-1 (PD-1) or programmed death-ligand 1 (PD-L1) inhibitor, and a platinum-containing chemotherapy. Urothelial cancer, also known as transitional cell carcinoma, is a type of cancer that affects the urothelial cells lining the bladder and other parts of the urinary tract.

Enfortumab vedotin-ejfv is a type of antibody-drug conjugate (ADC) that targets a protein called Nectin-4, which is found on the surface of cancer cells. It delivers a cytotoxic agent directly to the cancer cells, thereby killing them. This medication is typically used when the cancer has progressed despite prior treatments.

How should this medicine be used?

As for how Enfortumab vedotin-ejfv injection is used:

• Dosage: The dosage of Enfortumab vedotin-ejfv is calculated based on the patient’s body weight. It is administered intravenously (IV) over a certain period, typically once every three weeks.
• Administration: Enfortumab vedotin-ejfv injection is administered by a healthcare professional in a clinical setting, such as a hospital or infusion center.
• Precautions: Before administering the injection, healthcare providers may take precautions such as pre-medicating the patient to reduce the risk of infusion reactions.
• Monitoring: During treatment, patients are monitored closely for any adverse reactions or side effects. This may include regular blood tests to check for changes in blood cell counts and liver function.
• Duration: Treatment with Enfortumab vedotin-ejfv injection may continue until disease progression or until the patient experiences unacceptable side effects.

It’s important for patients to follow their healthcare provider’s instructions closely regarding the administration and monitoring of Enfortumab vedotin-ejfv injection. Any questions or concerns about the medication should be discussed with a healthcare professional.

Other uses for this medicine

As for other uses of Enfortumab vedotin-ejfv, it is primarily indicated for the treatment of urothelial cancer as described above. It is not typically used for other types of cancer or conditions unless specifically prescribed by a healthcare professional for an off-label use.

What special precautions should I follow?

Enfortumab vedotin-ejfv is a medication used for the treatment of certain types of cancer, such as urothelial cancer. When taking Enfortumab vedotin-ejfv injection, it’s crucial to follow specific precautions to ensure safety and effectiveness. Here are some general precautions:

• Medical Supervision: Enfortumab vedotin-ejfv is typically administered by healthcare professionals in a clinical setting such as a hospital or clinic. Follow your doctor’s instructions closely regarding dosage and administration.
• Allergy Screening: Inform your healthcare provider about any allergies you may have, especially to medications, latex, or any ingredients in Enfortumab vedotin-ejfv.
• Pregnancy and Breastfeeding: Inform your doctor if you are pregnant, planning to become pregnant, or breastfeeding. The potential risks and benefits of Enfortumab vedotin-ejfv should be discussed with your doctor in these situations.
• Monitoring: Your doctor may conduct regular monitoring of your blood cell counts, liver function, and other parameters to check for any potential side effects or adverse reactions.
• Side Effects: Be aware of potential side effects of Enfortumab vedotin-ejfv, such as fatigue, nausea, decreased appetite, hair loss, and peripheral neuropathy. Contact your healthcare provider if you experience any severe or persistent side effects.
• Infection Risk: Enfortumab vedotin-ejfv may increase your risk of developing infections. Take precautions to avoid exposure to infectious agents, such as washing your hands frequently and avoiding contact with sick individuals.
• Fertility: Enfortumab vedotin-ejfv may affect fertility in both men and women. Discuss fertility preservation options with your doctor before starting treatment if this is a concern for you.
• Drug Interactions: Inform your doctor about all medications, supplements, and herbal remedies you are taking, as Enfortumab vedotin-ejfv may interact with certain medications.
• Storage and Handling: Store Enfortumab vedotin-ejfv as directed by your healthcare provider or pharmacist. Follow proper handling procedures to avoid contamination.

Always consult with your healthcare provider or pharmacist for personalized advice and guidance regarding Enfortumab vedotin-ejfv and any specific precautions you should follow based on your individual health status and medical history.

What special dietary instructions should I follow?

There are no specific dietary restrictions associated with Enfortumab vedotin-ejfv injection. However, maintaining a balanced diet and staying hydrated may help support overall health during treatment. It’s essential to follow any dietary recommendations provided by your healthcare provider to manage any side effects or complications related to cancer treatment.

What should I do if I forget a dose?

If you miss a dose of Enfortumab vedotin-ejfv injection, contact your healthcare provider immediately for guidance. Do not attempt to administer the missed dose on your own or double up on doses to make up for the missed one. Your healthcare provider will advise you on the appropriate course of action based on your individual treatment plan and circumstances. It’s crucial to adhere to the prescribed dosing schedule to maximize the effectiveness of the medication and maintain the best possible outcomes in cancer treatment.

What side effects can this medication cause?

Enfortumab vedotin-ejfv injection, like many medications, can cause side effects. These side effects can vary in severity from person to person. Some common side effects associated with Enfortumab vedotin-ejfv injection include:

• Fatigue: Feeling tired or weak is a common side effect of Enfortumab vedotin-ejfv treatment.
• Nausea and vomiting: Some individuals may experience nausea, vomiting, or both during or after treatment.
• Peripheral neuropathy: Enfortumab vedotin-ejfv can cause damage to the nerves, leading to symptoms such as numbness, tingling, or weakness in the hands and feet.
• Decreased appetite: Some people may experience a decreased appetite while receiving Enfortumab vedotin-ejfv treatment.
• Diarrhea or constipation: Changes in bowel habits, including diarrhea or constipation, can occur as a side effect of Enfortumab vedotin-ejfv.
• Hair loss: Enfortumab vedotin-ejfv may cause hair loss or thinning, although this side effect is less common compared to some other chemotherapy drugs.
• Skin reactions: Skin reactions such as rash, itching, or dry skin may occur in some individuals.
• Changes in taste: Some people may notice changes in their sense of taste, such as a metallic taste in the mouth.
• Anemia: Enfortumab vedotin-ejfv can cause a decrease in red blood cell count, leading to anemia and symptoms such as fatigue and weakness.
• Decreased white blood cell count: This can increase the risk of infections.
• Liver toxicity: Enfortumab vedotin-ejfv may affect liver function, leading to elevated liver enzymes and potentially causing liver damage.
• Infusion reactions: Some individuals may experience infusion reactions, which can include symptoms like fever, chills, flushing, shortness of breath, or changes in blood pressure.

It’s important to note that not all individuals will experience these side effects, and some may experience side effects not listed here. Additionally, side effects can vary in intensity and may resolve on their own or with supportive care. It’s essential for individuals receiving Enfortumab vedotin-ejfv treatment to communicate any side effects they experience to their healthcare provider, as they can provide guidance and support to manage them effectively.

What should I know about storage and disposal of this medication?

Storage and Disposal:

• Storage: Enfortumab vedotin-ejfv Injection should be stored in its original carton in a refrigerator at 2°C to 8°C (36°F to 46°F). Do not freeze or shake the vial. Protect the vial from light by keeping it in its carton until ready for use. Do not use Enfortumab vedotin-ejfv Injection after the expiration date printed on the label.
• Disposal: Unused Enfortumab vedotin-ejfv Injection or materials used to prepare the injection should be disposed of properly in accordance with local regulations for hazardous waste disposal. Do not dispose of Enfortumab vedotin-ejfv Injection in household trash or wastewater.

In case of emergency/overdose

In case of an emergency or overdose, contact your healthcare provider, local emergency services, or a poison control center immediately for assistance. It’s important to seek medical help right away if you suspect an overdose or if you experience severe adverse reactions or symptoms.

What other information should I know?

• Other Information: Before starting treatment with Enfortumab vedotin-ejfv Injection, inform your healthcare provider about all your medical conditions, including any allergies, current medications (prescription and over-the-counter), and supplements you are taking. Also, inform them if you are pregnant, planning to become pregnant, or breastfeeding.
• Follow-up: Attend all scheduled appointments with your healthcare provider for monitoring and follow-up during Enfortumab vedotin-ejfv treatment. They will assess your response to treatment, monitor for side effects, and make any necessary adjustments to your treatment plan.
• Support Services: Seek support from your healthcare team, as well as from family, friends, or support groups, if you have concerns or questions about your treatment with Enfortumab vedotin-ejfv Injection. They can provide information, assistance, and emotional support throughout your treatment journey.
• Patient Education: Make sure to understand the proper administration technique for Enfortumab vedotin-ejfv Injection if you are administering it at home. Follow the instructions provided by your healthcare provider or pharmacist carefully to ensure safe and effective use of the medication.
• Report Side Effects: If you experience any side effects or adverse reactions while receiving Enfortumab vedotin-ejfv Injection, report them to your healthcare provider immediately. They can provide guidance on managing side effects and may need to adjust your treatment plan accordingly.

By following these guidelines and staying informed about Enfortumab vedotin-ejfv Injection, you can help ensure safe and effective treatment for your condition.